Hansa had asked the FDA to consider a priority review of its biologics licensing application (BLA) for imlifidase, which was ...

Cardiff, Wales-based Antiverse's computational platform has been set up to find antibodies against challenging drug targets, ...

New research has lent weight to the intriguing idea that GLP-1 agonists may have a role to play in helping people with substance use disorders (SUD) break their addiction. A meta-analysis carried out ...

What emerged through such discussions was not optimism nor was it pessimism, but clarity. The consensus was striking in its consistency across sessions. JPM 2026 signalled genuine recovery – but not ...

The study analysed two years of search ads linked to Ozempic.com. An estimated $7.5m was spent on 15,000+ keywords, ...

The latest phase of the long-running scheme – run by Cancer Research UK (CRUK) and the National Cancer Institute (NCI) in the ...

Arbutus and Genevant's complaint claimed that Moderna's mRNA-based Spikevax shot used lipid nanoparticle (LNP) delivery technology, which enables the safe and effective delivery of nucleic acid ...

The UK government is providing nearly £50 million in funding for equipment that it says will help the NHS carry out ...

Kyowa Kirin has terminated all clinical trials of its anti-OX40L antibody rocatinlimab, after cases of cancer were seen in ...

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now, it’s possible to connect your data and tool ecosystem. There is a gold rush happening in ...

McKinnon discusses ‘white space’ in R&D, about integrating generative and agentic AI with human-in-the-loop oversight while ...

The FDA announced a concerted action against direct-to-consumer (DTC) advertising of pharma products last September, and has since sent thousands of letters warning pharmaceutical and telehealth firms ...